These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110. [Possibility of evaluating the effectiveness of renal artery sympathetic denervation in resistant hypertension early after radiofrequency ablation]. Rebrova TY; Ripp TM; Afanasiev SA; Mordovin VF; Muslimova EF Ter Arkh; 2016; 88(8):10-13. PubMed ID: 27636920 [TBL] [Abstract][Full Text] [Related]
111. Renal Sympathetic Denervation by CT-Guided Ethanol Injection: A Phase II Pilot Trial of a Novel Technique. Ricke J; Seidensticker M; Becker S; Schiefer J; Adamchic I; Lohfink K; Kandulski M; Heller A; Mertens PR Cardiovasc Intervent Radiol; 2016 Feb; 39(2):251-60. PubMed ID: 26634740 [TBL] [Abstract][Full Text] [Related]
112. Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive Medications. Hameed MA; Pucci M; Martin U; Watkin R; Doshi S; Freedman J; Riley P; Townend J; Crowe P; Lipkin G; Dasgupta I J Clin Hypertens (Greenwich); 2016 Jun; 18(6):565-71. PubMed ID: 26434739 [TBL] [Abstract][Full Text] [Related]
113. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension. Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461 [TBL] [Abstract][Full Text] [Related]
114. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL; J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423 [TBL] [Abstract][Full Text] [Related]
115. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Mahfoud F; Urban D; Teller D; Linz D; Stawowy P; Hassel JH; Fries P; Dreysse S; Wellnhofer E; Schneider G; Buecker A; Schneeweis C; Doltra A; Schlaich MP; Esler MD; Fleck E; Böhm M; Kelle S Eur Heart J; 2014 Sep; 35(33):2224-31b. PubMed ID: 24603307 [TBL] [Abstract][Full Text] [Related]
117. Vascular and renal hemodynamic changes after renal denervation. Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677 [TBL] [Abstract][Full Text] [Related]
118. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters. Ammar S; Ladich E; Steigerwald K; Deisenhofer I; Joner M EuroIntervention; 2013 May; 9 Suppl R():R89-95. PubMed ID: 23732162 [TBL] [Abstract][Full Text] [Related]
119. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Worthley SG; Tsioufis CP; Worthley MI; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Papademetriou V Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649 [TBL] [Abstract][Full Text] [Related]
120. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]